SEC Form 4 · accession 0001144204-15-016837
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence Mehren
Officer — PRESIDENT AND CEO · Director
Period of report
Mar 17, 2015
Accepted (ET)
Mar 17, 2015 · 7:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 17, 2015 | P | 500 | $20.48 | A | 500 | D | |
| Common StockF2 | holding | — | — | — | 1,576,792 | I | Through MAB, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at various prices. The reporting person undertakes to provide Accelerate Diagnostics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- F2The reporting person is the manager of MAB, LLC and in that capacity has sole voting and dispositive power with respect to the shares held by it. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.